Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
Russia hits power plants, kills four, leaves Kyiv under smoke
US forces exit remaining bases in Iraq
Shark stranded in South Korean canal draws 600,000 visitors as rescue bid fails
Israeli strikes kill five people in Gaza, medics say
Norway parliament probes Epstein links to politicians, diplomats
